Examples of doping control analysis by liquid chromatography-tandem mass spectrometry:: Ephedrines, β-receptor blocking agents, diuretics, sympathornimetics, and cross-linked hemoglobins

被引:40
作者
Thevis, M [1 ]
Schänzer, W [1 ]
机构
[1] German Sport Univ Cologne, Inst Biochem, D-50933 Cologne, Germany
关键词
D O I
10.1093/chromsci/43.1.22
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The application of modern and powerful analytical instruments consisting of liquid chromatographs (LCs), sophisticated atmospheric pressure ion sources, and sensitive mass analyzers has improved quality as well as speed of doping control analyses markedly during the last 5 years. Numerous compounds such as β-receptor blocking agents or diuretics require derivatization prior to gas chromatographic (GC) and mass spectrometric (MS) measurement, which is the reason for extended sample preparation periods. In addition, several substances demonstrate poor GC-MS properties even after chemical modification, and peptide hormones such as cross-linked hemoglobins cannot be analyzed at all by means of GC-MS. With the availability of electrospray ionization and robust tandem MSs (e.g., triple-stage quadrupole or ion trap instruments) many new or complementary screening and confirmation assays have been developed, providing detailed qualitative and quantitative information on prohibited drugs. With selected categories of compounds (ephedrines, β-blockers, β2-agonists, diuretics, and bovine hemoglobin-based oxygen therapeutics) that are banned according to the rules of the World Anti-Doping Agency and International Olympic Committee, the advantages of LC-MS-MS procedures over conventional GC-MS assays are demonstrated, such as enhanced separation of analytes, shorter sample pretreatment, and identification of substances that are not identified by GC-MS.
引用
收藏
页码:22 / 31
页数:10
相关论文
共 105 条
[1]   Screening urine for exogenous testosterone by isotope ratio mass spectrometric analysis of one pregnanediol and two androstanediols [J].
Aguilera, R ;
Catlin, DH ;
Becchi, M ;
Phillips, A ;
Wang, C ;
Swerdloff, RS ;
Pope, HG ;
Hatton, CK .
JOURNAL OF CHROMATOGRAPHY B, 1999, 727 (1-2) :95-105
[2]  
ALMA C, 2002, RECENT ADV DOPING AN, P169
[3]   Determination of clenbuterol in human urine by GC-MS-MS-MS:: confirmation analysis in antidoping control [J].
Amendola, L ;
Colamonici, C ;
Rossi, F ;
Botrè, F .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 773 (01) :7-16
[4]  
Ariens EJ, 1965, DOPING P INT SEMINAR, P27
[5]  
AXELROD J, 1954, J PHARMACOL EXP THER, V110, P315
[6]   Testing for natural and synthetic anabolic agents in human urine [J].
Ayotte, C ;
Goudreault, D ;
Charlebois, A .
JOURNAL OF CHROMATOGRAPHY B, 1996, 687 (01) :3-25
[7]   Transplanting functional properties from bovine into human hemoglobin [J].
Baudin, V ;
Kister, J ;
Poyart, C ;
Pagnier, J .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1995, 2 (06) :469-471
[8]   URINARY EXCRETION KINETICS OF AMPHETAMINE IN MAN [J].
BECKETT, AH ;
ROWLAND, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1965, 17 (10) :628-&
[9]   URINARY EXCRETION KINETICS OF METHYLAMPHETAMINE IN MAN [J].
BECKETT, AH ;
ROWLAND, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1965, S 17 :S109-&
[10]   URINARY EXCRETION OF (-)-METHYLEPHEDRINE (-)-EPHEDRINE AND (-)-NOREPHEDRINE IN MAN [J].
BECKETT, AH ;
WILKINSON, GR .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1965, S 17 :S107-+